CHROMOSOMAL STUDIES IN 24 PATIENTS WITH SECONDARY ACUTE MYELOID LEUKEMIAS (AML) AND MYELODYSPLASTIC SYNDROMES (MDS)

被引：0
作者：
WEH, HJ
HOFFMANN, R
SUCIU, S
KUSE, R
HOSSFELD, DK
机构：
[1] UNIV HAMBURG,MED KLIN,ONKOL & HAMATOL ABT,D-2000 HAMBURG 20,FED REP GER
[2] ALLGEMEINES KRANKENHAUS ST GEORG,HAMATOL ABT,D-2000 HAMBURG 1,FED REP GER
来源：
BLUT | 1987年 / 55卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [21] Molecular diagnostic testing patterns in patients (pts) with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) in the Connect MDS/AML Registry.
    George, Tracy
    Patel, Jay L.
    Abedi, Mehrdad
    Cogle, Christopher R.
    Erba, Harry Paul
    Garcia-Manero, Guillermo
    Grinblatt, David L.
    Kiselev, Pavel
    Komrokji, Rami S.
    Louis, Chrystal Ursula
    Maciejewski, Jaroslaw P.
    Nifenecker, Melissa
    Pollyea, Daniel Aaron
    Roboz, Gail J.
    Savona, Michael R.
    Scott, Bart L.
    Sekeres, Mikkael A.
    Steensma, David P.
    Thompson, Michael A.
    Foucar, Kathryn
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] HEXAMETHYLENE BISACETAMIDE (HMBA) IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    ANDREEFF, M
    STONE, R
    YOUNG, C
    TONG, W
    ERVIN, T
    TAFURI, A
    KOLITZ, J
    RIFKIND, R
    KUFE, D
    MARKS, P
    LEUKEMIA, 1991, 5 (02) : 174 - 174
  • [23] Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following a diagnosis of breast cancer
    Padmanabhan, A.
    Block, A.
    Sait, S.
    Ford, L. A.
    O'Connor, T. L.
    Moysich, K. B.
    Baer, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] REDIFINING MONOSOMY 20 BY MOLECULAR CYTOGENETICS IN 1.0 MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKEMIA (MDS/AML) PATIENTS
    Bernasconi, P.
    Dambruoso, I.
    Boni, M.
    Zappatore, R.
    Cavigliano, P. M.
    Giardini, I.
    Calatroni, S.
    Rocca, B.
    Caresana, M.
    Tarantino, P.
    Lazzarino, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 273 - 273
  • [25] Low dose Vidaza and thalidomide is an effective combination for patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
    Westervelt, P.
    Amirifeli, S.
    Mehdi, M.
    Mumtaz, M.
    Alhomsi, S.
    Wang, S.
    Miron, P.
    Lata, C.
    Galili, N.
    Raza, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 354S - 354S
  • [26] Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias
    Leone, Giuseppe
    D'Alo, Francesco
    Zardo, Giuseppe
    Voso, Maria Teresa
    Nervi, Clara
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (13) : 1274 - 1287
  • [27] CHROMOSOMAL RESULTS IN 50 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    LESSARD, M
    BRIZARD, A
    GUILHOT, F
    TANZER, J
    BLUT, 1988, 56 (06): : C9 - C9
  • [28] SECONDARY MYELODYSPLASTIC SYNDROMES AND LEUKEMIAS
    LEVINE, EG
    BLOOMFIELD, CD
    CLINICS IN HAEMATOLOGY, 1986, 15 (04): : 1037 - 1080
  • [29] Distinction of Early and Late Molecular Events In Patients with Myelodysplastic Syndromes (MDS) Who Progressed to Acute Myeloid Leukemia (AML)
    Afable, Manuel G., II
    Makishima, Hideki
    Sakaguchi, Hirotoshi
    Jerez, Andres
    Jankowska, Anna Malgorzata
    Guinta, Kathryn M.
    Abu Kar, Sara
    Traina, Fabiola
    Sugimoto, Yuka
    O'Keefe, Christine
    Tiu, Ramon V.
    Sekers, Mikkael A.
    Maciejewski, Jaroslaw P.
    BLOOD, 2011, 118 (21) : 1522 - 1523
  • [30] A PHASE I STUDY OF THE COMBINATION OF AZACITIDINE AND ORAL RIGOSERTIB IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) OR ACUTE MYELOID LEUKEMIA (AML)
    Navada, S. C.
    Garcia-Manero, G.
    Hearn, K.
    Odchimar-Reissig, R.
    Demakos, E.
    Alvarado, Y.
    Daver, N.
    DiNardo, C.
    Konopleva, M.
    Borthakur, G.
    Azarnia, N.
    Silverman, L. R.
    LEUKEMIA RESEARCH, 2015, 39 : S45 - S45
12345